Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency

(3-Carboline is a crucial compound in medicinal chemistry known for its versatile pharmacological activities. Recent research has focused on hybrid molecules incorporating a (3-carboline scaffold linked to other pharmacophore moieties. These hybrid compounds have demonstrated diverse therapeutic pro...

詳細記述

書誌詳細
出版年:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
主要な著者: Sulaiman, Nur Fatihah; Zulkifli, Siti Zafirah; Saaidin, Aimi Suhaily; Lekkala, Ravindar; Hassan, Nurul Izzaty; Pungot, Noor Hidayah
フォーマット: Review
言語:English
出版事項: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER 2025
主題:
オンライン・アクセス:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001432422300001
author Sulaiman
Nur Fatihah; Zulkifli
Siti Zafirah; Saaidin
Aimi Suhaily; Lekkala
Ravindar; Hassan
Nurul Izzaty; Pungot
Noor Hidayah
spellingShingle Sulaiman
Nur Fatihah; Zulkifli
Siti Zafirah; Saaidin
Aimi Suhaily; Lekkala
Ravindar; Hassan
Nurul Izzaty; Pungot
Noor Hidayah
Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
Pharmacology & Pharmacy
author_facet Sulaiman
Nur Fatihah; Zulkifli
Siti Zafirah; Saaidin
Aimi Suhaily; Lekkala
Ravindar; Hassan
Nurul Izzaty; Pungot
Noor Hidayah
author_sort Sulaiman
spelling Sulaiman, Nur Fatihah; Zulkifli, Siti Zafirah; Saaidin, Aimi Suhaily; Lekkala, Ravindar; Hassan, Nurul Izzaty; Pungot, Noor Hidayah
Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
English
Review
(3-Carboline is a crucial compound in medicinal chemistry known for its versatile pharmacological activities. Recent research has focused on hybrid molecules incorporating a (3-carboline scaffold linked to other pharmacophore moieties. These hybrid compounds have demonstrated diverse therapeutic properties, including anticancer, antianxiety, antimalarial, antidepressant, anti-inflammatory, antileishmanial, and antioxidant effects. This review highlights studies conducted from 2014 to the present with a particular emphasis on the development of (3-carboline hybrid compounds and their derivatives as potent anticancer agents. The structure-activity relationship (SAR) analysis reveals that these hybrids exhibit significant cytotoxicity against various cancer cell lines. This review aims to inspire further research into the novel synthesis and evolution of (3-carboline hybrids and their derivatives, potentially leading to new therapeutic advancements.
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
0223-5234
1768-3254
2025
288

10.1016/j.ejmech.2025.117412
Pharmacology & Pharmacy

WOS:001432422300001
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001432422300001
title Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
title_short Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
title_full Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
title_fullStr Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
title_full_unstemmed Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
title_sort Exploring β-carboline hybrids and their derivatives: A review on synthesis and anticancer efficiency
container_title EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
language English
format Review
description (3-Carboline is a crucial compound in medicinal chemistry known for its versatile pharmacological activities. Recent research has focused on hybrid molecules incorporating a (3-carboline scaffold linked to other pharmacophore moieties. These hybrid compounds have demonstrated diverse therapeutic properties, including anticancer, antianxiety, antimalarial, antidepressant, anti-inflammatory, antileishmanial, and antioxidant effects. This review highlights studies conducted from 2014 to the present with a particular emphasis on the development of (3-carboline hybrid compounds and their derivatives as potent anticancer agents. The structure-activity relationship (SAR) analysis reveals that these hybrids exhibit significant cytotoxicity against various cancer cell lines. This review aims to inspire further research into the novel synthesis and evolution of (3-carboline hybrids and their derivatives, potentially leading to new therapeutic advancements.
publisher ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
issn 0223-5234
1768-3254
publishDate 2025
container_volume 288
container_issue
doi_str_mv 10.1016/j.ejmech.2025.117412
topic Pharmacology & Pharmacy
topic_facet Pharmacology & Pharmacy
accesstype
id WOS:001432422300001
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001432422300001
record_format wos
collection Web of Science (WoS)
_version_ 1828987785326886912